Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Porter

Showing results (71-80 of 297) with videos related to

Pageof 30
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2014
Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancersGemma M Ryan, Lisa M Kaminskas, Christopher J H Porter
Molecular Pharmaceutics|October 21, 2010
Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?Natalie L Trevaskis, William N Charman, Christopher J H Porter
Biopharmaceutics & Drug Disposition|April 17, 2003
Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine In Vivo?David M Shackleford, Christopher J H Porter, William N Charman
AAPS Pharmsci|March 21, 2003
An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestineBrendan M Johnson, William N Charman, Christopher J H Porter
Nanomedicine (London, England)|September 30, 2011
Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME propertiesLisa M Kaminskas, Ben J Boyd, Christopher J H Porter
Molecular Pharmaceutics|October 15, 2011
Correction to "targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?"Natalie L Trevaskis, William N Charman, Christopher J H Porter
Nature Reviews. Drug Discovery|October 17, 2015
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activityNatalie L Trevaskis, Lisa M Kaminskas, Christopher J H Porter
Molecular Pharmaceutics|April 3, 2023
Introducing the Molecular Pharmaceutics Special Issue on "Emerging Trends in Molecular Pharmaceutics across Australasia"Orlagh M Feeney, Christopher J H Porter, Kara L Vine
Journal of Pharmaceutical Sciences|August 29, 2013
Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in ratsKathy Wai Yu Lee, Christopher J H Porter, Ben J Boyd
AAPS Pharmscitech|June 5, 2013
A simple quantitative approach for the determination of long and medium chain lipids in bio-relevant matrices by high performance liquid chromatography with refractive index detectionKathy Wai Yu Lee, Christopher J H Porter, Ben J Boyd
Pageof 30

Showing results (71-80 of 297) with videos related to

Sort By:
Pageof 30
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2014
Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancersGemma M Ryan, Lisa M Kaminskas, Christopher J H Porter
Molecular Pharmaceutics|October 21, 2010
Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?Natalie L Trevaskis, William N Charman, Christopher J H Porter
Biopharmaceutics & Drug Disposition|April 17, 2003
Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine In Vivo?David M Shackleford, Christopher J H Porter, William N Charman
AAPS Pharmsci|March 21, 2003
An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestineBrendan M Johnson, William N Charman, Christopher J H Porter
Nanomedicine (London, England)|September 30, 2011
Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME propertiesLisa M Kaminskas, Ben J Boyd, Christopher J H Porter
Molecular Pharmaceutics|October 15, 2011
Correction to "targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?"Natalie L Trevaskis, William N Charman, Christopher J H Porter
Nature Reviews. Drug Discovery|October 17, 2015
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activityNatalie L Trevaskis, Lisa M Kaminskas, Christopher J H Porter
Molecular Pharmaceutics|April 3, 2023
Introducing the Molecular Pharmaceutics Special Issue on "Emerging Trends in Molecular Pharmaceutics across Australasia"Orlagh M Feeney, Christopher J H Porter, Kara L Vine
Journal of Pharmaceutical Sciences|August 29, 2013
Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in ratsKathy Wai Yu Lee, Christopher J H Porter, Ben J Boyd
AAPS Pharmscitech|June 5, 2013
A simple quantitative approach for the determination of long and medium chain lipids in bio-relevant matrices by high performance liquid chromatography with refractive index detectionKathy Wai Yu Lee, Christopher J H Porter, Ben J Boyd
Pageof 30